This test detects 14 high-risk HPV types in a single tube and is a clinically validated, FDA-approved, and WHO-prequalified ...
"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said ...
4 天
Asian News International on MSNMetropolis Healthcare Launches High-performance High-Risk HPV DNA Testing to Accelerate ...Ameera Shah-led Metropolis Healthcare Limited, India's second-largest and most respected pathology laboratory chain, today ...
For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) that causes it was safe and yielded complete response in many cases, a small ...
Metropolis Healthcare and Roche Diagnostics India introduce self-sampling HPV DNA test for cervical cancer screening at home.
Cervical cancer remains a major health challenge for Indian women, despite being preventable through early screening and ...
Opens in a new tab or window For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) that causes it was safe and yielded ...
A South African scientist is pioneering a DNA methylation test that aims to enhance the early detection of cervical cancer.
Mumbai (Maharashtra) [India], February 6: Ameera Shah-led Metropolis Healthcare Limited, India’s second-largest and most respected pathology laboratory chain, today announced its collaboration with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果